• Target：
• CYP4Z1

• Gene Name：
• CYP4Z1

• Protein Name：
• Cytochrome P450 4Z1

• Human Gene Id：
• 199974

• Human Swiss Prot No：
• Q86W10

• Immunogen：
• The antiserum was produced against synthesized peptide derived from human Cytochrome P450 4Z1. AA range:71-120

• Specificity：
• CYP4Z1 Polyclonal Antibody detects endogenous levels of CYP4Z1 protein.

• Formulation：
• Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

• Source：
• Polyclonal, Rabbit,IgG

• Dilution：
• WB 1:500-2000 IHC 1:100 - 1:300. IF 1:200 - 1:1000. ELISA: 1:20000. Not yet tested in other applications.

• Purification：
• The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

• Concentration：
• 1 mg/ml

• Storage Stability：
• -15°C to -25°C/1 year(Do not lower than -25°C)

• Other Name：
• CYP4Z1;Cytochrome P450 4Z1;CYPIVZ1

• Molecular Weight(Da)：
• 59kD

• Background：
• CYP4Z1 encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. CYP4Z1 is part of a cluster of cytochrome P450 genes on chromosome 1p33.

• Function：
• oxidation reduction,

• Subcellular Location：
• Endoplasmic reticulum membrane ; Single-pass type II membrane protein . Microsome membrane ; Single-pass type II membrane protein .

• Expression：
• Preferentially detected in breast carcinoma tissue and mammary gland, whereas only marginal expression is found in all other tested tissues.

• June 19-2018
• WESTERN IMMUNOBLOTTING PROTOCOL

• June 19-2018
• IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL

• June 19-2018
• IMMUNOFLUORESCENCE PROTOCOL

• September 08-2020
• FLOW-CYTOMEYRT-PROTOCOL

• May 20-2022
• Cell-Based ELISA│解您多样本WB检测之困扰

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN

• July 13-2018
• CELL-BASED-COLORIMETRIC-ELISA-PROTOCOL-FOR-TOTAL-PROTEIN

• July 13-2018
• Antibody-FAQs